Top 5 Cancer Stories
April 2014
 
 
 
Version 2/AQ: The QX200™ AutoDG™ Droplet Digital™ PCR system is here. The automated droplet generator minimizes hands-on time, eliminates user-to-user variability, and makes every droplet count. Learn more >
 
 
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Senior Editor
Companies will develop and commercialize AVEO's ficlatuzumab with a Biodesix companion diagnostic
 
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Senior Editor
The biomarker appears in some 15 percent of myeloproliferative neoplasms, and a CALR diagnostic is expected to complement QIAGEN's existing JAK2 kits
 
From DDNews Online:
By Lloyd Dunlap, DDNews Managing Editor
GlaxoSmithKline plc and Genmab A/S have announced that the U.S. Food and Drug Administration has approved a Supplemental Biologic License Application for the use of Arzerra (ofatumumab), a CD20-directed monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukemia
 
From DDNews Daily News:
By Lloyd Dunlap, DDNews Managing Editor
Committee votes favorably on safety and finds the benefits of Epi proColon outweigh the risks; asks for more data on long-term effectiveness
 
From our April 2014 issue:
By Kelsey Kaustinen, DDNews Senior Editor
The collaboration is the second established as part of the Moon Shots Program in two months
 
 
 
 
   
©2014 Old River Publications LLC. All Rights Reserved.
Web site designed and managed by Offenberger & White, Inc..
If you no longer wish to receive DDNEWS mailings, please unsubscribe here.